This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
health insurers report billions as small providers face stress in the first quarter. The nation’s largest health insurer, UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 compared to $3.4bn in the same period in 2020 – a 44% increase. The answer may be in offering a value-based healthcare model.
Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). Healthcare professionals are in great need of quality educational materials, yet it can seem like most pharmaceutical companies prefer running ads instead.
Adding responsibilities of testing for COVID-19 and administering the vaccine in mass volumes when it became available, pharmacists and techs had to shuffle workload and priorities in a way that supported this critical role as healthcareproviders. Given the convenience of the local pharmacy to most in the U.S.,
We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcareproviders to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . Prescription refills. Patient verification. Elderly care.
Survival of the fittest: Biotech reset “Horrible” and “carnage” were how some described the early 2022 environment for biotech financing, as funding fell significantly below the highs of 2020 and 2021, and IPOs all but dried up. A longer historic view of biotech funding, however, reverses the picture: 2020 and 2021 were not normal years.
The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The No Surprises Act (NSA), signed into law in December 2020, and the Transparency in Coverage Rule (TiC), published in October 2020, will have significant implications for health plans in 2022.
Pharmaceutical brands often take a backseat role in patient health by encouraging patients to talk to their healthcareprovider about treatment options. However, today’s healthcare consumers are asking for a different approach. What Does This Mean for Your Brand?
Prescription refills can now be placed with a simple click on a patient portal. What if you scan a QR code on the box or bottle and it would trigger an approval from your healthcareprovider? In December 2020, RB launched the Cough, Cold, and Flu Navigator with WebMD.
Let’s get to the point: It’s time for pharma marketers and their media agencies to look beyond the “usual suspects” for new ways and new media partners to reliably deliver educational and promotional messages to healthcareproviders (HCPs) specifically when they are in an action mindset.
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 355(q), [link] govinfo.gov/content/pkg/USCODE-2020-title21/pdf/USCODE-2020-title21-chap9- subchapV-partA-sec355.pdf; Measuring and rating biosimilar access. pdf; 21 C.F.R. 562, 117th Cong. §
We know that today's healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcareproviders to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . consumers at the beginning of 2020, when the COVID-19 pandemic hit.
Much like how many consumers are turning to Amazon or Instacart delivery instead of in-store shopping during the pandemic, early data suggests that large swaths of the US population are choosing telehealth encounters instead of in-person visits with their healthcareproviders. In some states, the observed rate went as high as 23%.
In an effort to reduce the hazards connected with their use, regulations seek to regulate the prescription and distribution of these drugs. Case Summary: In 2020, this company agreed to pay $678 million to settle allegations that it violated the False Claims Act by paying kickbacks to doctors. Department of Justice, 2020).
As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.
Healthcare is a shining example of creative development in the quickly evolving world of digital technology. These intelligent digital assistants are revolutionizing how healthcareproviders interact with patients, boosting engagement, streamlining support services, and enhancing patient experiences.
Though 80% of healthcareproviders (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. Updated June 8, 2020. Increasing Market Awareness Remains a Challenge. Updated March 23, 2018. FirstWord PHARMA.
Health inequities in oncology clinical trials In 2020, nearly 5,000 patients participated in clinical trials for 18 newly approved oncology drugs, however, the FDA reported that a disproportionate percent of those participants were White. Clarify launched its real-world evidence on health disparities in 2021.
Suddenly, I was looking at healthcare through a different lens that offered new clarity for what I feel is my role and responsibility as a healthcare marketer. Caregiving has reached crisis proportions in American healthcare, where cradle-to-grave care is no longer guaranteed. In 2020, 41.8 adult population.
In this deep dive, we will explore how much do pharmaceutical sales reps make, the factors that influence pharmaceutical sales rep salaries and provide insights into what you can expect in terms of compensation in this field. Experience and Expertise Experience in the pharmaceutical sales industry often correlates with a higher rep salary.
In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content